PBF-1681 (Ferric Citrate) for the Treatment of IDA in Patients With NDD-CKD

NCT04543812 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
141
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Panion & BF Biotech Inc.